SG11201809799WA - Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions - Google Patents
Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditionsInfo
- Publication number
- SG11201809799WA SG11201809799WA SG11201809799WA SG11201809799WA SG11201809799WA SG 11201809799W A SG11201809799W A SG 11201809799WA SG 11201809799W A SG11201809799W A SG 11201809799WA SG 11201809799W A SG11201809799W A SG 11201809799WA SG 11201809799W A SG11201809799W A SG 11201809799WA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- subunit
- compounds
- voltage
- pain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382199 | 2016-05-06 | ||
| PCT/EP2017/060780 WO2017191304A1 (en) | 2016-05-06 | 2017-05-05 | Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201809799WA true SG11201809799WA (en) | 2018-12-28 |
Family
ID=56024209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201809799WA SG11201809799WA (en) | 2016-05-06 | 2017-05-05 | Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US10590140B2 (es) |
| EP (1) | EP3452475B1 (es) |
| JP (1) | JP6926197B2 (es) |
| KR (1) | KR20190024876A (es) |
| CN (1) | CN109526220B (es) |
| AR (1) | AR108387A1 (es) |
| AU (1) | AU2017260305B2 (es) |
| BR (1) | BR112018072755A2 (es) |
| CA (1) | CA3023379A1 (es) |
| CO (1) | CO2018012002A2 (es) |
| CY (1) | CY1123231T1 (es) |
| DK (1) | DK3452475T3 (es) |
| ES (1) | ES2789676T3 (es) |
| HR (1) | HRP20200668T1 (es) |
| HU (1) | HUE051829T2 (es) |
| IL (1) | IL262825A (es) |
| LT (1) | LT3452475T (es) |
| ME (1) | ME03726B (es) |
| MX (1) | MX2018013471A (es) |
| MY (1) | MY196791A (es) |
| PH (1) | PH12018502337A1 (es) |
| PL (1) | PL3452475T3 (es) |
| PT (1) | PT3452475T (es) |
| RS (1) | RS60528B1 (es) |
| RU (1) | RU2018141084A (es) |
| SG (1) | SG11201809799WA (es) |
| SI (1) | SI3452475T1 (es) |
| TN (1) | TN2018000372A1 (es) |
| TW (1) | TWI736619B (es) |
| UA (1) | UA123789C2 (es) |
| WO (1) | WO2017191304A1 (es) |
| ZA (1) | ZA201807653B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3697754A1 (en) * | 2017-10-16 | 2020-08-26 | Esteve Pharmaceuticals, S.A. | Propanamine derivatives for treating pain and pain related conditions |
| KR20200097694A (ko) * | 2017-10-27 | 2020-08-19 | 에스테베 파마슈티칼스 에스에이 | 통증 및 통증 관련 상태를 치료하기 위한 신규한 알콕시아미노 유도체 |
| AR113910A1 (es) * | 2017-12-04 | 2020-06-24 | Esteve Pharmaceuticals Sa | Derivados de o-fenoxi y o-benciloxipropilamino con actividad contra el dolor |
| WO2019115008A1 (en) * | 2017-12-12 | 2019-06-20 | Esteve Pharmaceuticals, S.A. | Dialkylaminoarylpiperidinyl-o-phenoxy and o-benzyloxypropylamino derivatives having multimodal activity against pain |
| WO2019149919A1 (en) * | 2018-02-05 | 2019-08-08 | Esteve Pharmaceuticals, S.A. | Aminopropoxypiperidinylamido derivatives having multimodal activity against pain |
| WO2020089263A1 (en) * | 2018-10-31 | 2020-05-07 | Esteve Pharmaceuticals, S.A. | Optionally nitrogenated isoquinolin-1(2h)-ones and 1h-isochromen- 1-ones for treating pain and pain related conditions |
| AR116972A1 (es) * | 2018-11-02 | 2021-06-30 | Esteve Pharmaceuticals Sa | Derivados de alcoxiaminopiridina para tratar dolor y estados relacionados con dolor |
| JP2022506378A (ja) * | 2018-11-02 | 2022-01-17 | エステベ ファーマシューティカルズ，ソシエダッド アノニマ | 疼痛及び疼痛に関連する状態を処置するための新規なテトラヒドロピリミドジアゼピン及びテトラヒドロピリドジアゼピン化合物 |
| US20220204481A1 (en) * | 2019-02-28 | 2022-06-30 | Osaka University | Protein and/or peptide modification molecule |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03002649A (es) * | 2000-09-27 | 2003-09-25 | Ajinomoto Kk | Derivado de benzodiazepina. |
| AU2003239752A1 (en) | 2002-06-27 | 2004-01-19 | Warner-Lambert Company Llc | Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder |
| JPWO2005085210A1 (ja) * | 2004-03-10 | 2008-01-17 | 小野薬品工業株式会社 | ニトリル化合物およびその化合物を有効成分として含有する医薬組成物 |
| ZA200806871B (en) * | 2006-02-14 | 2009-10-28 | Vertex Pharma | Dihydrodiazepines useful as inhibitors of protein kinases |
| TW200914457A (en) * | 2007-05-31 | 2009-04-01 | Kyowa Hakko Kogyo Kk | Pyrimidodiazepinone derivative |
| UY32622A (es) * | 2009-05-12 | 2010-12-31 | Astrazeneca Ab | Nuevos compuestos para el tratamiento de patologías relacionadas con ab(beta) |
-
2017
- 2017-05-05 SG SG11201809799WA patent/SG11201809799WA/en unknown
- 2017-05-05 RU RU2018141084A patent/RU2018141084A/ru unknown
- 2017-05-05 UA UAA201811326A patent/UA123789C2/uk unknown
- 2017-05-05 PT PT177216801T patent/PT3452475T/pt unknown
- 2017-05-05 ME MEP-2020-101A patent/ME03726B/me unknown
- 2017-05-05 HU HUE17721680A patent/HUE051829T2/hu unknown
- 2017-05-05 ES ES17721680T patent/ES2789676T3/es active Active
- 2017-05-05 KR KR1020187032195A patent/KR20190024876A/ko not_active Application Discontinuation
- 2017-05-05 BR BR112018072755-5A patent/BR112018072755A2/pt not_active IP Right Cessation
- 2017-05-05 TW TW106114980A patent/TWI736619B/zh not_active IP Right Cessation
- 2017-05-05 DK DK17721680.1T patent/DK3452475T3/da active
- 2017-05-05 US US16/098,244 patent/US10590140B2/en active Active
- 2017-05-05 WO PCT/EP2017/060780 patent/WO2017191304A1/en unknown
- 2017-05-05 AU AU2017260305A patent/AU2017260305B2/en not_active Ceased
- 2017-05-05 EP EP17721680.1A patent/EP3452475B1/en active Active
- 2017-05-05 JP JP2019510471A patent/JP6926197B2/ja active Active
- 2017-05-05 MY MYPI2018704135A patent/MY196791A/en unknown
- 2017-05-05 CN CN201780042378.XA patent/CN109526220B/zh active Active
- 2017-05-05 TN TNP/2018/000372A patent/TN2018000372A1/en unknown
- 2017-05-05 RS RS20200595A patent/RS60528B1/sr unknown
- 2017-05-05 AR ARP170101172A patent/AR108387A1/es unknown
- 2017-05-05 CA CA3023379A patent/CA3023379A1/en not_active Abandoned
- 2017-05-05 PL PL17721680T patent/PL3452475T3/pl unknown
- 2017-05-05 SI SI201730239T patent/SI3452475T1/sl unknown
- 2017-05-05 LT LTEP17721680.1T patent/LT3452475T/lt unknown
- 2017-05-05 MX MX2018013471A patent/MX2018013471A/es unknown
-
2018
- 2018-11-06 IL IL262825A patent/IL262825A/en unknown
- 2018-11-06 PH PH12018502337A patent/PH12018502337A1/en unknown
- 2018-11-14 ZA ZA2018/07653A patent/ZA201807653B/en unknown
- 2018-11-29 CO CONC2018/0012002A patent/CO2018012002A2/es unknown
-
2020
- 2020-04-26 HR HRP20200668TT patent/HRP20200668T1/hr unknown
- 2020-05-25 CY CY20201100472T patent/CY1123231T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201809799WA (en) | Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions | |
| SG11201810117WA (en) | Human platelet lysate derived extracellular vesicles for use in medicine | |
| SG11201811338VA (en) | A novel botulinum neurotoxin and its derivatives | |
| SG11201810423XA (en) | Pd-1 / pd-l1 inhibitors for cancer treatment | |
| SG11201807708SA (en) | Estrogen receptor modulators | |
| SG11201909963YA (en) | Methods for treating dravet syndrome | |
| SG11201807809XA (en) | A transient commensal microorganism for improving gut health | |
| SG11201811442UA (en) | Formulation of a peptide vaccine | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201901534VA (en) | Combination therapy with controlled-release cnp agonists | |
| SG11201810280YA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201407837WA (en) | Beta-hairpin peptidomimetics | |
| SG11201810352XA (en) | New antibacterial compounds | |
| SG11201907356SA (en) | Piperidine-substituted mnk inhibitors and methods related thereto | |
| SG11201906543RA (en) | HDAC INHIBITORS-BASED ANTIBODY DRUG CONJUGATES (ADCs) AND USE IN THERAPY | |
| SG11201805001UA (en) | Method of treating influenza a | |
| SG11201810561YA (en) | Liquid neurotoxin formulation stabilized with tryptophan or tyrosine | |
| SG11201901986SA (en) | Process for the manufacture of a solid pharmaceutical adminstration form | |
| SG11201407536UA (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
| SG11201900043TA (en) | Antibody formulations | |
| SG11201908691PA (en) | Compounds and methods for the treatment of parasitic diseases | |
| SG11201407114YA (en) | Novel dosage and formulation | |
| SG11201900214UA (en) | Iso-citrate dehydrogenase (idh) inhibitor | |
| SG11201811311VA (en) | Compounds for imaging tau protein aggregates | |
| SG11201901689YA (en) | Compounds for treating diseases associated with a mitochondrial dysfonction |